Abstract
TWELVE patients with moderately severe angina pectoris completed a double blind cross-over comparison of conventional propranolol (40 mg q.i.d.) and Inderal L.A. (160 mg once daily) with regard to therapeutic effectiveness, blood levels, compliance and patient acceptability.
Exercise tolerance was assessed using standardised treadmill testing at 1, 2, 4, 8, 12 and 24 hours after the morning dose. The double placebo technique was used.
Patient compliance was excellent for both regimes and no serious side effects were reported. No significant differences in exercise tolerance or blood levels were observed between the two treatments at any time.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chidsey C. A., Morselli P., Bianchetti G., Morganti A., Leonetti G., Zanchetti A. Studies of the absorption and removal of propranolol in hypertensive patients during therapy. Circulation. 1975 Aug;52(2):313–318. doi: 10.1161/01.cir.52.2.313. [DOI] [PubMed] [Google Scholar]
- McAinsh J., Baber N. S., Smith R., Young J. Pharmacokinetic and pharmacodynamic studies with long-acting propranolol. Br J Clin Pharmacol. 1978 Aug;6(2):115–121. doi: 10.1111/j.1365-2125.1978.tb00835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller R. R., Olson H. G., Pratt C. M., Amsterdam E. Z., Mason D. T. Efficacy of beta adrenergic blockade in coronary heart disease: propranolol in angina pectoris. Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):598–605. doi: 10.1002/cpt1975185part1598. [DOI] [PubMed] [Google Scholar]
- Shand D. G., Nuckolls E. M., Oates J. A. Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112–120. doi: 10.1002/cpt1970111112. [DOI] [PubMed] [Google Scholar]
- Sheffield L. T., Roitman D. Stress testing methodology. Prog Cardiovasc Dis. 1976 Jul-Aug;19(1):33–49. doi: 10.1016/0033-0620(76)90007-4. [DOI] [PubMed] [Google Scholar]